Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013)
Titel:
Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013)
Auteur:
Witte, Theo de Suciu, Stefan Meert, Liv Halkes, Constantijn Selleslag, Dominik Bron, Dominique Amadori, Sergio Willemze, Roel Muus, Petra Baron, Frédéric